Literature DB >> 18378787

Concomitant use of beta-blockers and beta2-agonists.

Y Ling, W Saleem, C D Shee.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18378787     DOI: 10.1183/09031936.00153707

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  5 in total

1.  Current perspectives on treatment of hypertensive patients with chronic obstructive pulmonary disease.

Authors:  Dipak Chandy; Wilbert S Aronow; Maciej Banach
Journal:  Integr Blood Press Control       Date:  2013-07-09

2.  Beta-blockers reduced the risk of mortality and exacerbation in patients with COPD: a meta-analysis of observational studies.

Authors:  Qingxia Du; Yongchang Sun; Ning Ding; Lijin Lu; Ying Chen
Journal:  PLoS One       Date:  2014-11-26       Impact factor: 3.240

3.  Identifying Drug-Therapy Problems among Syrian Refugees in Zaatari Refugee Camp.

Authors:  Alaa M Hammad; Walid Al-Qerem; Fawaz Alasmari; Jonathan Ling; Raghda Qarqaz; Hakam Alaqabani
Journal:  Int J Environ Res Public Health       Date:  2022-06-12       Impact factor: 4.614

4.  Drugs potentially affecting the extent of airways reversibility on pulmonary function testing are frequently consumed despite guidelines.

Authors:  Terry E Jones; AnneMarie Southcott; Sean Homan
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2013-08-09

5.  Ivabradine prevents heart rate acceleration in patients with chronic obstructive pulmonary disease and coronary heart disease after salbutamol inhalation.

Authors:  Rustem Zulkarneev; Naufal Zagidullin; Guzel Abdrahmanova; Uta C Hoppe; Shamil Zagidullin
Journal:  Pharmaceuticals (Basel)       Date:  2012-04-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.